23th PAGE Meeting

Alicante - Spain
10-13 June, 2014

View abstracts

Home / 2014 – Alicante – Spain / Abstracts

← Back to filters

Abstracts (20)

I-13Eva Germovsek

Mechanistic Modelling of Total Body CD4 T-cell Counts from Paediatric HIV Patients Undergoing Planned Treatment Interruption

Wednesday 10:20-11:50

I-33Rollo Hoare

Modelling CD4 lymphocyte reconstitution following paediatric haematopoietic stem cell transplantation

Wednesday 10:20-11:50

I-38Esther Janssen

Simulations of vancomycin exposure throughout childhood upon commonly used dosing guidelines: towards a model-based dosing regimen

Wednesday 10:20-11:50

II-06Jean Lavigne

Modeling and simulation of dihydroartemisinin (DHA) after administration of Eurartesim® (piperaquine tetraphosphate/DHA)

Wednesday 15:10-16:30

II-13

Evaluation of tetrahydrobiopterin responsiveness in neonates with hyperphenylalaninemia

Wednesday 15:10-16:30

II-17

PPK analysis of Rouvastatin in Children and Adolescents (ages 6 to <18 years of age) with Familial Hypercholesterolemia to Support Regulatory Approval

Wednesday 15:10-16:30

II-20Andreas Matthios

Dosing recommendation for gabapentin in chronic paediatric pain

Wednesday 15:10-16:30

II-21Johanna Melin

Population pharmacokinetic analysis of hydrocortisone in paediatric patients with adrenal insufficiency

Wednesday 15:10-16:30

II-30Hussain Mulla

Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.

Wednesday 15:10-16:30

II-32Flora Musuamba-Tshinanu

Optimisation of tacrolimus-based immunosuppressive treatment in pediatric solid organ transplantation: A model-based approach.

Wednesday 15:10-16:30

II-46Sophie Peigné

Paediatric PK predictions and population analysis

Wednesday 15:10-16:30

II-51

A Prospective Population Pharmacokinetic (PK) Analysis of Sapropterin Dihydrochloride in Infants and Young Children with Phenylketonuria (PKU)

Wednesday 15:10-16:30

III-03Rick Admiraal

Population pharmacokinetic modeling of Thymoglobulin in children receiving allogeneic-hematopoietic cell transplantation (HCT): towards individualized dosing to improve survival

Thursday 10:05-11:30

III-29Elisa Calvier

Use of semi-physiological covariate model for maturation of glucuronidation to scale from adults to children

Thursday 10:05-11:30

IV-07Stephan Schmidt

Evaluation of changes in oral drug absorption in preterm neonates for BCS class I and II compounds

Thursday 15:15-16:40

IV-34Pyry Välitalo

Evaluation of gentamicin and tobramycin dosing guidelines for neonates; towards model-based dosing

Thursday 15:15-16:40

IV-38Anne van Rongen

Population pharmacokinetics of a single intravenous dose of midazolam in obese, overweight and non-obese adolescents

Thursday 15:15-16:40

IV-43Chenguang Wang

Population pharmacokinetics of paracetamol across the human age-range from (pre)term neonates, infants, children to adults

Thursday 15:15-16:40

IV-58Morris Muliaditan

Population Pharmacokinetic Meta-Analysis of the Antiretroviral Agent Lamivudine in HIV-Infected Children

Thursday 15:15-16:40

IV-59Oscar Della Pasqua

Population Pharmacokinetic Meta-Analysis of the Antiretroviral Agent Abacavir in HIV-Infected Children

Thursday 15:15-16:40